Senti Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Senti Biosciences, Inc. (SNTI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-52.79-71.06-58.21-55.32-19.86
Depreciation & Amortization5.855.433.563.011.99
Stock Based Compensation1.769.6716.392.300.27
Change in Working Capital4.04-0.371.210.62-1.78
Change in Accounts Receivable-0.73-0.93-0.13-0.40-0.01
Change in Accounts Payable0.80-0.290.19-0.62-0.32
Change in Other Working Capital5.765.99-9.6114.74-1.61
Other Operating Activities5.7635.7730.7314.74-5.03
Net Cash from Operating Activities-41.40-52.40-34.90-34.64-24.17
Investing Activities
Capital Expenditures-0.03-12.0441.37-5.54-1.16
Acquisitions0.00-0.21-9.460.000.00
Purchases of Investments0.0042.01-40.590.0012.52
Sales/Maturities of Investments0.00-17.99-40.590.000.00
Other Investing Activities0.060.000.000.000.00
Net Cash from Investing Activities0.0330.08-81.96-5.5411.36
Financing Activities
Debt Repayment0.00-0.110.000.000.00
Common Stock Issued49.060.890.881.500.33
Other Financing Activities4.670.00111.98-0.02-0.28
Net Cash from Financing Activities53.730.78118.5568.4438.05
Summary
Net Change in Cash12.37-21.541.7028.2625.24
Cash at Beginning of Period39.4560.9959.2931.030.00
Cash at End of Period51.82-70.2960.9959.290.00
Free Cash Flow-41.42-52.40-76.27-40.18-25.33